FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166847523> ?p ?o ?g. }

• W3166847523 abstract "ABSTRACT Chemotherapy is a common treatment for breast cancer (BrCa) and can cause chemotherapy‐induced peripheral neuropathy (CIPN). CIPN contributes to falls, and is thus a potential risk factor for nontraumatic fractures (NTFx); yet, the effect of CIPN on NTFx risk has not been examined for BrCa survivors. We therefore investigated the association between CIPN and NTFx in BrCa survivors. Data were extracted from Optum's Deidentified Clinformatics® Data Mart Database years 2010–2015 in this retrospective cohort study. Among women, three groups were derived based on BrCa and CIPN status: BrCa+/CIPN+ (primary group of interest), BrCa+/CIPN− (first comparison group), and BrCa−/CIPN− (second comparison group). After propensity score matching the comparison groups to BrCa+/CIPN+ at a ratio of 1:11 (BrCa:control) for demographics, osteoporosis, glucocorticoid medication, comorbidities, and cancer‐related variables for BrCa+/CIPN−, 1‐year incidence rate (IR) of NTFx was determined for each group. The incident rate ratio (IRR) determined if the IR for NTFx was different for BrCa+/CIPN+ compared to BrCa+/CIPN− and BrCa−/CIPN−. Cox proportional hazards regression models estimated the hazard ratios (HRs) after adjusting for covariates that were unable to be matched for. The crude IR (95% confidence interval [CI]) of NTFx was 4.54 (2.32–6.77) for BrCa+/CIPN+ ( n = 359), 2.53 (2.03–3.04) for BrCa+/CIPN− ( n = 3949), and 1.76 (1.35–2.18) for BrCa−/CIPN− ( n = 3949). The crude IRR of NTFx was significantly elevated for BrCa+/CIPN+ as compared to BrCa+/CIPN− (IRR = 1.80; 95% CI, 1.06–3.05) and BrCa−/CIPN− (IRR = 2.58; 95% CI, 1.50–4.44). The elevated rate of NTFx for BrCa+/CIPN+ remained unchanged after adjusting for aromatase inhibitors compared to BrCa+/CIPN− (HR = 1.79; 95% CI, 1.06–3.04). Female BrCa survivors have an increased 1‐year IR of NTFx after the onset of CIPN, suggesting that CIPN is an additive burden on NTFx risk among BrCa survivors. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research." @default.
• W3166847523 created "2021-06-22" @default.
• W3166847523 creator A5001026720 @default.
• W3166847523 creator A5013069001 @default.
• W3166847523 creator A5030604253 @default.
• W3166847523 creator A5070154639 @default.
• W3166847523 date "2021-06-10" @default.
• W3166847523 modified "2023-10-17" @default.
• W3166847523 title "Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors" @default.
• W3166847523 cites W1818272034 @default.
• W3166847523 cites W1970782797 @default.
• W3166847523 cites W1976627713 @default.
• W3166847523 cites W1985732101 @default.
• W3166847523 cites W1999609152 @default.
• W3166847523 cites W2001537247 @default.
• W3166847523 cites W2020578652 @default.
• W3166847523 cites W2037504501 @default.
• W3166847523 cites W2062071281 @default.
• W3166847523 cites W2063665805 @default.
• W3166847523 cites W2082753946 @default.
• W3166847523 cites W2088110780 @default.
• W3166847523 cites W2096982348 @default.
• W3166847523 cites W2114458368 @default.
• W3166847523 cites W2117538544 @default.
• W3166847523 cites W2118616448 @default.
• W3166847523 cites W2125734294 @default.
• W3166847523 cites W2137458001 @default.
• W3166847523 cites W2139959697 @default.
• W3166847523 cites W2146721164 @default.
• W3166847523 cites W2149764798 @default.
• W3166847523 cites W2153483480 @default.
• W3166847523 cites W2156938611 @default.
• W3166847523 cites W2214791105 @default.
• W3166847523 cites W2241843730 @default.
• W3166847523 cites W2359816812 @default.
• W3166847523 cites W2499794029 @default.
• W3166847523 cites W2509936361 @default.
• W3166847523 cites W2511608227 @default.
• W3166847523 cites W2529035719 @default.
• W3166847523 cites W2555207714 @default.
• W3166847523 cites W2593764183 @default.
• W3166847523 cites W2604286481 @default.
• W3166847523 cites W2615584788 @default.
• W3166847523 cites W2735301415 @default.
• W3166847523 cites W2748150722 @default.
• W3166847523 cites W2845774993 @default.
• W3166847523 cites W2883869140 @default.
• W3166847523 cites W2923906605 @default.
• W3166847523 cites W2925662761 @default.
• W3166847523 cites W2951549972 @default.
• W3166847523 cites W2963166017 @default.
• W3166847523 cites W2964928975 @default.
• W3166847523 cites W2965460641 @default.
• W3166847523 cites W2971810224 @default.
• W3166847523 cites W2972037715 @default.
• W3166847523 cites W2972042810 @default.
• W3166847523 cites W2973754763 @default.
• W3166847523 cites W2974078499 @default.
• W3166847523 cites W2981974627 @default.
• W3166847523 cites W2989216877 @default.
• W3166847523 cites W3000070994 @default.
• W3166847523 cites W3007296169 @default.
• W3166847523 cites W3007305713 @default.
• W3166847523 cites W3011749932 @default.
• W3166847523 cites W3013785204 @default.
• W3166847523 cites W3017910916 @default.
• W3166847523 cites W3135620381 @default.
• W3166847523 cites W53490872 @default.
• W3166847523 doi "https://doi.org/10.1002/jbm4.10519" @default.
• W3166847523 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8328798" @default.
• W3166847523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34368609" @default.
• W3166847523 hasPublicationYear "2021" @default.
• W3166847523 type Work @default.
• W3166847523 sameAs 3166847523 @default.
• W3166847523 citedByCount "4" @default.
• W3166847523 countsByYear W31668475232022 @default.
• W3166847523 crossrefType "journal-article" @default.
• W3166847523 hasAuthorship W3166847523A5001026720 @default.
• W3166847523 hasAuthorship W3166847523A5013069001 @default.
• W3166847523 hasAuthorship W3166847523A5030604253 @default.
• W3166847523 hasAuthorship W3166847523A5070154639 @default.
• W3166847523 hasBestOaLocation W31668475233 @default.
• W3166847523 hasConcept C121608353 @default.
• W3166847523 hasConcept C126322002 @default.
• W3166847523 hasConcept C134018914 @default.
• W3166847523 hasConcept C143998085 @default.
• W3166847523 hasConcept C17923572 @default.
• W3166847523 hasConcept C207103383 @default.
• W3166847523 hasConcept C2779289229 @default.
• W3166847523 hasConcept C2779901536 @default.
• W3166847523 hasConcept C44249647 @default.
• W3166847523 hasConcept C50382708 @default.
• W3166847523 hasConcept C530470458 @default.
• W3166847523 hasConcept C555293320 @default.
• W3166847523 hasConcept C71924100 @default.
• W3166847523 hasConcept C72563966 @default.
• W3166847523 hasConceptScore W3166847523C121608353 @default.
• W3166847523 hasConceptScore W3166847523C126322002 @default.
• W3166847523 hasConceptScore W3166847523C134018914 @default.
• W3166847523 hasConceptScore W3166847523C143998085 @default.

• next